Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03419988 · ClinicalTrials.gov registry record · NA

Cell Signaling and Resistance to Oxidative Stress: Effects of Aging and Exercise

A NA study of Aging, sponsored by Northern Arizona University.

Completed
Registry status
NA
Development phase
46
Enrollment target
1
Study location

NCT03419988 is a NA study of Aging that has completed, run by Northern Arizona University. The registered enrollment target is 46 participants, below the 2,195-participant average among 262 other Aging trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03419988, a NA study of Aging, has completed, sponsored by Northern Arizona University.

COMPLETED
Registry status
NA
Development phase
46 participants
Enrollment target
1
Study location

Study Summary

Advanced age is the main risk factor for chronic diseases such as cardiovascular disease, type 2 diabetes, Alzheimer's disease and cancer. One reason may be due to decreased resistance to oxidative stress as antioxidant defenses and cell protection is reduced with aging. This has been shown in animal studies and also that the impairment can be somewhat restored with exercise. This will be the first study to test this in humans by comparing young and older inactive adults before and after an exercise intervention, a practical and cost-effective intervention that can have tremendous public health impact by lowering risk for disease and medical-related costs.

Conditions Studied

Interventions

  • BEHAVIORAL Exercise Intervention

Study Locations (1)

Arizona

  • Northern Arizona University - Flagstaff

Trial Details

FieldValue
Enrollment Target 46 participants
Start Date 2017-06-01
Est. Completion 2020-06-30
Phase NA

Sponsor

Northern Arizona University

23 total trials

What the Registry Record Tells You About NCT03419988

The ClinicalTrials.gov registry entry for NCT03419988 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 46 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,195-participant average among 262 other Aging trials with a reported enrollment target (98% lower). The listed sponsor is Northern Arizona University, which has 23 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Aging appearing as the primary indexed condition, and to 1 intervention - of which Exercise Intervention is the first listed.

NCT03419988 reports 1 study location spanning 1 distinct geographic area - top geographies include Arizona.

Frequently Asked Questions

What is clinical trial NCT03419988 about?

NCT03419988 is a clinical study titled "Cell Signaling and Resistance to Oxidative Stress: Effects of Aging and Exercise". Advanced age is the main risk factor for chronic diseases such as cardiovascular disease, type 2 diabetes, Alzheimer's disease and cancer. One reason may be due to decreased resistance to oxidative stress as antioxidant defenses and cell protection is reduced with aging. This has been shown in anima...

What is the current status of trial NCT03419988?

This trial is currently completed. It is a NA study. The enrollment target is 46 participants. The study started on 2017-06-01. Estimated completion is 2020-06-30.

What conditions does trial NCT03419988 study?

This clinical trial studies the following conditions: Aging.

What interventions are being tested in trial NCT03419988?

The interventions under investigation include: Exercise Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT03419988?

This trial is sponsored by Northern Arizona University, which has 23 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03419988 being conducted?

This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Aging

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.